Neuronetics Inc
Neuronetics Inc logo
STIM

Neuronetics Inc (STIM)

$4.290.46%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$4.11
Day's Range
$4.36
$1.98
52-Week Range
$8.12
1 month return18.41%
3 month return72.4%
1 year return45.24%
5 year return84.49%

Company Information

Neuronetics, Inc. is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its commercial product, the NeuroStar® Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The system is cleared by the United States Food and Drug Administration, or FDA, for the treatment of major depressive disorder in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode. Visit NeuroStar.com for safety information and indications for use. NeuroStar is also available in other parts of the world, including Japan, where it is listed under Japan's national health insurance.
OrganizationNeuronetics Inc
Employees126
CEO
IndustryHealth Technology

Analyst Recommendation

based on 11 analysts ratings

Buy
72%
Buy
27%
Hold
0%
Sell

Based on 11 Wall street analysts offering stock ratings for Neuronetics Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 132.56%

Current

$4.3

Target

$10.0

Recommendation Trend

Based on 11 analyst

Current1M Ago3M Ago
Buy
8
8
8
Hold
3
3
3
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
71.1M
Book Value
3.23
Dividend Share
0.0
Dividend Yield
0.0
Earnings Share
-1.22
Wall Street Target Price
9.67

Valuation

Trailing PE0.0
Forward PE0.0
Price/Sales (ttm)
1.28
Price/Book (mrq)
0.89
Enterprise Value
19.3M
Enterprise Value/Revenue
0.35
Enterprise Value/Ebitda
0.07

Technicals

Beta
2.35
50 Day MA
3.07
200 Day MA
5.36

Institutional Holdings

Cannell Capital LLC

10.27%

Schroder Investment Management Group

6.77%

Archon Capital Management LLC

6.73%

BlackRock Inc

5.96%

Vanguard Group Inc

3.98%

Parian Global Management LP

3.57%

Discover more

Frequently Asked Questions

What is Neuronetics Inc share price today?

Can Indians buy Neuronetics Inc shares?

How can I buy Neuronetics Inc shares from India?

Can Fractional shares of Neuronetics Inc be purchased?

What are the documents required to start investing in Neuronetics Inc stocks?

What are today’s High and Low prices of Neuronetics Inc?

What are today’s traded volumes of Neuronetics Inc?

What is today’s market capitalisation of Neuronetics Inc?

What is the 52 Week High and Low Range of Neuronetics Inc?

How much percentage Neuronetics Inc is down from its 52 Week High?

How much percentage Neuronetics Inc is up from its 52 Week low?

What are the historical returns of Neuronetics Inc?

Who is the Chief Executive Officer (CEO) of Neuronetics Inc?